Andrew Leber, PhD

NIMML Institute

Poster(s):

• P2215 - Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn’s Disease
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2216 - Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2217 - Transcriptional Analysis of Colonic Biopsies from Patients with Ulcerative Colitis Treated with Omilancor
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT